Lloyd Rowland - Dec 20, 2023 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
General Counsel
Signature
/s/ Lloyd Rowland
Stock symbol
CTMX
Transactions as of
Dec 20, 2023
Transactions value $
-$5,629
Form type
4
Date filed
12/22/2023, 04:11 PM
Previous filing
Dec 19, 2023
Next filing
Jan 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale -$5.63K -4.08K -3.99% $1.38 98K Dec 20, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs previously reported on December 19, 2023.
F2 Includes 41,875 restricted stock units.